Trend Results : Johns Hopkins Medicine

Blog Post Results (1-20 of 369)


Does the affordable care act impact patient visits in the emergency department?

(Johns Hopkins Medicine) As the debate surrounding the Affordable Care Act (ACA) looms in the US Congress, Johns Hopkins researchers are weighing in on one aspect of the law. In 2014, as part of the ACA, Maryland was one of the states that expanded eligibility for its Medicaid program. Show More Summary

Small survey: Most primary care physicians can't identify all risk factors for prediabetes

(Johns Hopkins Medicine) Johns Hopkins researchers who distributed a survey at a retreat and medical update for primary care physicians (PCPs) report that the vast majority of the 140 doctors who responded could not identify all 11 risk factors that experts say qualify patients for prediabetes screening. Show More Summary

Faster diagnosis of inherited and lethal nerve disease could advance search for new treatments

(Johns Hopkins Medicine) Johns Hopkins physicians report success in a small study of a modified skin biopsy that hastens the earlier diagnosis of an inherited and progressively fatal nerve disease and seems to offer a clearer view of the disorder's severity and progression. Show More Summary

Researchers Find Handwritten Opioid Prescriptions Are More Prone to Mistakes

In a small study of opioid prescriptions filled at a Johns Hopkins Medicine outpatient pharmacy, researchers found that handwritten orders for the drugs contribute heavily to a trio of prescribing and processing errors in contrast to those created electronically.

Success With First 20 Patients Undergoing Minimally Invasive Pancreatic Transplant Surgery

Surgeons at Johns Hopkins Medicine report that their first series of a minimally invasive procedure to treat chronic pancreas disease, known as severe pancreatitis, resulted in shorter hospital stays, less need for opioids and fewer complications, compared with standard surgical approaches.

Barrier Proteins in Tumors are Possible Key to Immunotherapy Success

(Johns Hopkins Medicine) By comparing variations in protein expression in tumor samples from a single melanoma patient, researchers from the Johns Hopkins Bloomberg~Kimmel Institute and the Memorial Sloan-Kettering Cancer Center say their findings have the potential to reveal some of the mechanisms underlying response or resistance to immunotherapy drugs.

Molecular test for common causes of vaginitis receives FDA approval

(Johns Hopkins Medicine) Johns Hopkins researchers report that a molecular diagnostic test accurately distinguishes among the three most common causes of vaginitis, an inflammation of vaginal tissue they say accounts for millions of visits to medical clinics and offices in the US each year.

Mouse eyes constrict to light without direct link to the brain

Experimenting with mice, neuroscientists at Johns Hopkins Medicine report new evidence that the eye's iris in many lower mammals directly senses light and causes the pupil to constrict without involving the brain.

All Slots for Prestigious Neuro-Oncology Fellowship Filled by UAMS Residents

Two residents from the University of Arkansas for Medical Sciences (UAMS) have been selected for a prestigious fellowship in neuro-oncology administered jointly by the Johns Hopkins University School of Medicine and the National Institutes of Health Neuro-Oncology Branch.

Better outcome measures needed for clinical trials for Fragile X Syndrome

(Johns Hopkins Medicine) A group of researchers from several institutions in the USA, including Johns Hopkins Medicine, reports that its review of 22 clinical trials of fragile X syndrome (FXS) suggests the need for a wider use of newer and improved treatment outcome measurement tools for this and other several neurodevelopmental disorders. Show More Summary

The One Health Company teams with the Johns Hopkins University School of Medicine

(AJL Consulting) The One Health Company is pleased to announce a new relationship with the Johns Hopkins University School of Medicine to evaluate a therapy that potentially could be used to treat cancer in both dogs and humans.

Martin G. Pomper, MD, PhD, receives SNMMI Paul C. Aebersold Award in nuclear medicine

(Society of Nuclear Medicine) Martin G. Pomper, MD, PhD, director of nuclear medicine and molecular imaging and professor in the Russell H. Morgan Department of Radiology and Radiological Science at The Johns Hopkins University School of Medicine in Baltimore, Maryland, has been named the 2017 recipient of the prestigious Paul C. Show More Summary

Flaws in a tumor's genetic mending kit drive treatment response to immunotherapy

(Johns Hopkins Medicine) In an expanded, three-year clinical trial of 86 patients with colorectal and 11 other kinds of cancer that have so-called 'mismatch repair' genetic defects, scientists at Johns Hopkins Medicine and its Bloomberg~Kimmel Institute for Cancer Immunotherapy have found that half of the patients respond to an immunotherapy drug called pembrolizumab (Keytruda).

'Immunoswitch' particles may be key to more-effective cancer immunotherapy

(Johns Hopkins Medicine) Scientists at Johns Hopkins have created a nanoparticle that carries two different antibodies capable of simultaneously switching off cancer cells' defensive properties while switching on a robust anticancer immune response in mice. Show More Summary

Reservoirs of Latent HIV Can Grow Despite Effective Therapy, Study Shows

Researchers at Johns Hopkins Medicine report new evidence that immune cells infected with a latent form of human immunodeficiency virus (HIV) are able to proliferate, replenishing the reservoir of virus that is resistant to antiretroviral drug therapy. Show More Summary

Johns Hopkins Study Shows One of the Deadliest Hospital-Acquired Infections Is Preventable

In a recent paper published online in the journal Critical Care Medicine, researchers at the Johns Hopkins Armstrong Institute of Patient Safety and Quality led a study that demonstrated that health care providers can take steps to curb ventilator-associated events.

Gene sequencing study reveals unusual mutations in endometriosis

(Johns Hopkins Medicine) Using gene sequencing tools, scientists from Johns Hopkins Medicine and the University of British Columbia have found a set of genetic mutations in samples from 24 women with benign endometriosis, a painful disorder marked by the growth of uterine tissue outside of the womb. Show More Summary

Helping Clinicians Through Traumatic Events Also Helps the Bottom Line, Cost-Benefit Analysis Shows

A peer-support program launched six years ago at Johns Hopkins Medicine to help doctors and nurses recover after traumatic patient-care events such as a patient's death probably saves the institution close to $2 million annually, according to a recent cost-benefit analysis.

Cancer cells shown to co-opt DNA'repair crew'

(Johns Hopkins Medicine) In experiments with human colon cancer cells and mice, a team led by scientists at the Johns Hopkins Kimmel Cancer Center say they have evidence that cancer arises when a normal part of cells' machinery generally used to repair DNA damage is diverted from its usual task. Show More Summary

Helistroke service: Flying the physician to the stroke patient works

(Johns Hopkins Medicine) Flying a stroke specialist by helicopter to a nearby stroke patient for emergency care is feasible, saves money and, most importantly, gets critical care to patients faster than transporting the patient to a hospital first, according to a single-patient, proof-of-concept study by a Johns Hopkins Medicine research team.

Copyright © 2015 Regator, LLC